Mortality rate disparities in breast cancer with obesity: Insights from CDC WONDER analysis of two decades.

e13030 Background: Obesity is a significant risk factor for breast cancer, influencing its incidence and progression, and contributing to mortality. Analyzing two decades of CDC WONDER data provides insights into the mortality disparities associated with obesity in breast cancer patients. Methods: Death certificate data from the CDC WONDER database for adults aged ≥25 years (1999–2020) were analyzed. Crude mortality rates (CMRs) and age-adjusted mortality rates (AAMRs) per 100,000 persons were calculated. Temporal trends were assessed using annual percent change (APC) and average annual percent change (AAPC) via Joinpoint regression. Results: From 1999 to 2020, 1,895 individuals (female: 1,840; male: 55) died from breast cancer with obesity in the USA, with an overall AAMR of 0.03 (95% CI [0.03–0.03]). AAMRs showed an upward trend (AAPC: 5.77, 95% CI [3.23–8.37]; p<0.00001). Trends rose from 1999–2017 (APC: 2.80, 95% CI [0.77–4.86]; p=0.009) and sharply increased from 2017–2020 (APC: 25.47, 95% CI [9.24–44.12]; p=0.003).AAMRs were higher for women (0.07, 95% CI [0.07–0.07]) than men (0.0, 95% CI [0.0–0.0]), with identical APC/AAPC values for females (4.95, 95% CI [3.35–6.58]; p<0.005). Non-Hispanic (NH) African Americans had the highest AAMRs (0.09, 95% CI [0.08–0.10]), followed by NH Whites (0.02, 95% CI [0.01–0.03]) and Hispanic Whites (0.02, 95% CI [0.01–0.03]). NH Asians or Pacific Islanders (2.2, 95% CI [2.2–2.3]) and NH American Indians or Alaska Natives (2.9, 95% CI [2.7–3.1]) had the lowest AAMRs.Regionally, Nebraska had the highest AAMR (0.08), followed by Colorado, Oklahoma, and Oregon (0.06). While all regions shared an AAMR of 0.03 (95% CI [0.03–0.04]), the Midwest had the highest CMR (0.05, 95% CI [0.04–0.05]), followed by the South (0.04), West (0.04), and Northeast (0.03). Conclusions: Targeted interventions are needed to reduce breast cancer-related mortality with obesity, particularly among females, African Americans, and high-burden states. Efforts should focus on improving healthcare access, promoting screening, fostering lifestyle changes, addressing disparities, and ensuring culturally competent care to mitigate the burden in these vulnerable populations.

Authors

Institutions

Publication Details

Journal
Journal of Clinical Oncology
Published
2025-05-28
DOI
https://doi.org/10.1200/jco.2025.43.16_suppl.e13030
Primary Topic
Cancer Risks and Factors
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Mortality rate disparities in breast cancer with obesity: Insights from CDC WONDER analysis of two decades.

Adnan Bhat, Maria Qadri, Fatima Ashfaq, Haris Mumtaz Malik et al.
Journal of Clinical Oncology
Cancer Risks and Factors
article

Mortality rate disparities in breast cancer with obesity: Insights from CDC WONDER analysis of two decades.

Adnan Bhat, Maria Qadri, Fatima Ashfaq, Haris Mumtaz Malik, Waseem Nabi, Shafiq Ur Rahman, Muhammad Din Ibrahim
article en

Abstract

e13030 Background: Obesity is a significant risk factor for breast cancer, influencing its incidence and progression, and contributing to mortality. Analyzing two decades of CDC WONDER data provides insights into the mortality disparities associated with obesity in breast cancer patients. Methods: Death certificate data from the CDC WONDER database for adults aged ≥25 years (1999–2020) were analyzed. Crude mortality rates (CMRs) and age-adjusted mortality rates (AAMRs) per 100,000 persons were calculated. Temporal trends were assessed using annual percent change (APC) and average annual percent change (AAPC) via Joinpoint regression. Results: From 1999 to 2020, 1,895 individuals (female: 1,840; male: 55) died from breast cancer with obesity in the USA, with an overall AAMR of 0.03 (95% CI [0.03–0.03]). AAMRs showed an upward trend (AAPC: 5.77, 95% CI [3.23–8.37]; p<0.00001). Trends rose from 1999–2017 (APC: 2.80, 95% CI [0.77–4.86]; p=0.009) and sharply increased from 2017–2020 (APC: 25.47, 95% CI [9.24–44.12]; p=0.003).AAMRs were higher for women (0.07, 95% CI [0.07–0.07]) than men (0.0, 95% CI [0.0–0.0]), with identical APC/AAPC values for females (4.95, 95% CI [3.35–6.58]; p<0.005). Non-Hispanic (NH) African Americans had the highest AAMRs (0.09, 95% CI [0.08–0.10]), followed by NH Whites (0.02, 95% CI [0.01–0.03]) and Hispanic Whites (0.02, 95% CI [0.01–0.03]). NH Asians or Pacific Islanders (2.2, 95% CI [2.2–2.3]) and NH American Indians or Alaska Natives (2.9, 95% CI [2.7–3.1]) had the lowest AAMRs.Regionally, Nebraska had the highest AAMR (0.08), followed by Colorado, Oklahoma, and Oregon (0.06). While all regions shared an AAMR of 0.03 (95% CI [0.03–0.04]), the Midwest had the highest CMR (0.05, 95% CI [0.04–0.05]), followed by the South (0.04), West (0.04), and Northeast (0.03). Conclusions: Targeted interventions are needed to reduce breast cancer-related mortality with obesity, particularly among females, African Americans, and high-burden states. Efforts should focus on improving healthcare access, promoting screening, fostering lifestyle changes, addressing disparities, and ensuring culturally competent care to mitigate the burden in these vulnerable populations.

Journal of Clinical OncologyVol. 43(16_suppl)
Rawalpindi Medical University (PK), Nishtar Medical College and Hospital (PK), Saidu Teaching Hospital (PK), Wyckoff Heights Medical Center (US), Jinnah Sindh Medical University (PK), University of Florida (US), University of Science and Technology Bannu (PK)
Openalex Percentile: Top 81%
Cancer Risks and Factors
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.